白塞病
队列
内科学
优势比
前瞻性队列研究
共病
流行病学
人口
痹症科
儿科
置信区间
回顾性队列研究
作者
Cailin H. Sibley,Yusuf Yazici,Koray Tascilar,Nafiz Khan,Yasmin Bata,Hasan Yazici,Raphaela Goldbach-Mansky,Gulen Hatemi
标识
DOI:10.3899/jrheum.131227
摘要
Objective. To compare clinical manifestations and activity of Behcet syndrome (BS) in the United States versus Turkey using validated outcome measures. Methods. Consecutive patients with BS from the US National Institutes of Health (NIH), New York University, and the University of Istanbul were evaluated. Disease activity was measured using the Behcet’s Syndrome Activity Scale (BSAS) and the Behcet’s Disease Current Activity Form (BDCAF) with quality of life measured by the Behcet Disease Quality of Life (BDQOL) form. One-way ANOVA, t-tests, and multivariate regression analyses were performed. Results. Mean age did not differ between sites; however, more women were seen in the United States versus in Turkey (p Conclusion. Demographic and clinical manifestations of BS differ between sites with higher disease activity in the United States compared to Turkey. Referral patterns, age, sex, ethnicity, and country of origin may be important in these differences. These observations raise the question of whether pathogenic mechanisms differ in Turkish and American patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI